(Invitrogen)]. The precipitated DNA was then eluted and analyzed by dot-blotting using radiolabeled probes specific for telomeric sequence or Alu sequence.
Co-immunoprecipitation.
The assay was performed as described in (1) . Briefly, human U2OS cells (1 x 10 6 cells/mL) were transfected with two independent vectors containing Myc-SLX1 and HA-SLX4. 48 hours post transfection cells were resuspended in 800 µL lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Triton-X-100. 0.5 mM EDTA, 10% glycerol, and protease inhibitor cocktail from Roche) and incubated with gentle rocking at 4 °C for 1 hr. After spinning down the cell debris, SLX1-SLX4 protein complex was co-immunoprecipitated from the supernatant incubating cell lysate with 50 µL magnetic Dynabeads protein G (Invitrogen) conjugated with anti-HA antibody at 4 °C for 2 hr. Protein complex-bound bead suspension was then used in the nuclease assays.
Oligonucleotide-based assembly of telomeric substrates. Oligonucleotides used in this study were synthesized and purified (Loftstrand Labs) ( Table S1A ). The constituent oligonucleotides of each substrate are mentioned in Table S1B . Respective oligonucleotides (10 pmoles) were labeled at the 5'-end using [ 32 P]-γ-ATP and T4 polynucleotide kinase according to manufacturer's protocol. Oligonucleotides 1 (radiolabeled) and 2 were annealed in 1 M NaCl by heating to 95 °C for 5 min, followed by slow cooling from 65 °C to 25 °C, to assemble the splayed arm substrate. The 3'-flap substrate was assembled by first annealing oligonucleotides 4 and 2 (2.5:1) in an annealing buffer (10 mM Tris-HCl, pH 8.0 and 50 mM NaCl) by incubating at 95 °C for 5 min, followed by slow cooling from 65 °C to 25 °C. The above annealed mixture was set up for a second annealing with radiolabeled oligonucleotide 1 by incubating at 37 °C for 2 hrs, followed by slow cooling to 25 °C. The 5'-flap substrate was assembled by first annealing oligonucleotide 3 and radiolabeled oligonucleotide 1 (5:1) in the annealing buffer by incubating at 95 °C for 5 min, followed by slow cooling from 65 °C to 25 °C. The above annealed mixture was set up for a second annealing with oligonucleotide 2 by incubating at 37 °C for 2 hrs, followed by slow cooling to 25 °C. The replication fork substrate was assembled by first setting up two independent annealing reactions (labeled oligonucleotide 1 and oligonucleotide 3; and oligonucleotides 2 and 4). These two separate annealing reactions were then mixed and incubated at 37 °C for 2 hrs, followed by slow cooling to 25 °C. The D-loop substrate labeled on the DL-IV strand was assembled as described in (6) . The D-loop substrate labeled on the DL-T strand was assembled by first annealing oligonucleotides 9 and 11 (2:1) by incubating at 95 °C for 5 min and then 60 °C for 10 min. Radiolabeled oligonucleotide 10 was added to this annealing mixture, and incubated at 60 °C for 1 hr, followed by slow cooling to 25 °C. Similarly, the D-loop substrate labeled on DL-B strand was assembled by first annealing oligonucleotide 9 and radiolabeled oligonucleotide 11 (2:1), followed by addition of oligonucleotide 10. All substrates were purified using microspin G-25 spin columns (GE Healthcare), and verified for correct assembly via native gel electrophoresis.
Nuclease cleavage assays and TRF2/TRF1 protection assays. SLX1-dependent nuclease reactions were performed as described in (1) . Briefly, the reactions included 0.5 nM model telomeric substrates constructed from oligonucleotides in appropriate reaction buffer and were initiated by respective enzyme(s) (purified or immunoprecipitated) in concentrations as specified, followed by incubation at 37 °C for 30 min. Reactions were stopped and deproteinized at specified time points with stop buffer. BLM and SLX1-SLX4 dependent reactions contained both enzymes premixed (at specified concentrations), followed by initiation with radiolabeled substrate. Reaction products were analyzed by 10% native or 14% denaturing polyacrylamide gel electrophoresis. Dried gels were exposed to a BAS-phosphorimager screen, and images scanned using a Typhoon phosphorimager (GE Healthcare). Intensities of product bands were quantified using ImageQuant TL software (GE Healthcare). Figure S1 . Dissection of the SLX4 complex in preventing telomere fragility. 
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